在实践层面的严重性病例组合和治疗模式为绝经前非癌症子宫切除术
Joacy G Mathias1,2, Natalie A Rivadeneira3, Kemi M Doll4
1Division of Women's Community and Population Health, Department of Obstetrics and Gynecology, Duke University School of Medicine, Durham, North Carolina, USA.
Journal of women's health (2002)
|July 17, 2025
概括
腹腔切除术患者的症状严重程度较低,集中在私人保险人群中. 接受子宫切除术的西班牙裔,公共保险和无保险患者更有可能接受更严重的诊所治疗.
科学领域:
- 妇科外科手术 妇科外科手术
- 医疗服务研究 医疗服务研究
- 卫生公平性健康公平性
背景情况:
- 对于良性疾病的子宫切除术是对患者偏好敏感的,这导致在实践中症状严重程度的变化.
- 了解患者因种族,种族和保险状况的隔离与实践级症状严重程度的关系至关重要.
研究的目的:
- 调查非癌症条件下进行子宫切除术的患者中症状的严重程度是否与不同临床实践中的患者人口统计学 (种族,种族,保险状况) 相对相关.
主要方法:
- 分析了来自美国南方20个诊所的1590例子宫切除病例 (2014-2017年).
- 症状严重程度得分的发展 (出血,疼痛,体积) 来自手术前的笔记.
- 将做法分类为较低或较高严重程度的病例组合组.
- 逻辑-二项式模型来评估实践严重程度和患者特征之间的关联,调整混因素.
主要成果:
- 症状严重程度较低的诊所病例组合主要为私人保险患者提供服务 (96%).
- 在较低严重程度的实践中,西班牙裔患者的子宫切除率较低 (PR:0.52).
- 公共保险 (PR:0.13) 和无保险 (PR:0.28) 患者在较低严重程度的实践中接受子宫切除术的可能性明显较小.
结论:
- 根据保险状况和种族/种族,在子宫切除护理方面存在显著的差异.
- 公共保险或没有保险的患者,以及几乎所有西班牙裔患者,都集中在症状严重程度更高的实践中.
- 这表明护理的分离,脆弱人群在处理更复杂病例的环境中接受子宫切除术.
相关概念视频
01:24Disorders of the Female Reproductive System
496
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
496
01:28Menopause
252
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
252
01:12Hazard Ratio
257
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
257
01:21Cancer Survival Analysis
456
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
456